An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly disease, doctors reported Thursday—a breakthrough in the futuristic technology.
Two days after K.J. Muldoon was born prematurely, a neonatologist noticed he was sleepy and feeding poorly. The physician quickly ordered tests, which ultimately returned a grave diagnosis: a metabolic disease called severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, caused by a genetic mutation.
No comments :
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.